Quantification of the Visual Benefits of Soft Toric Contact Lenses Compared to Soft Spherical Contact Lenses

Astigmatism Clinical Trial

Official title:

Quantification of the Visual Benefits of Soft Toric Contact Lenses Compared to Soft Spherical Contact Lenses Over a Range of Refractive Astigmatism

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04613882
• Other study ID #: C19-683 (EX-MKTG-116)
• Status: Completed
• Phase: N/A
• Start date: September 28, 2021
• Est. completion date: June 21, 2022

Study information

• Verified date: May 2022
• Source: Coopervision, Inc.
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The aim of this work is to undertake a range of vision-related measures with soft toric contact lenses soft spherical contact lenses and spectacle lens correction across a range of levels of astigmatism.

Description:

This will be a randomised, crossover, partially subject-masked (for contact lenses only), non-dispensing study, controlled by cross-comparison.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 59
• Est. completion date: June 21, 2022
• Est. primary completion date: June 21, 2022
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 40 Years

Eligibility

Inclusion Criteria:

-

Subjects will only be eligible for the study if:

1. They are of legal age between 18 and 40 years.

2. They understand their rights as a research subject and are willing and able to sign a Statement of Informed Consent.

3. They are willing and able to follow the protocol.

4. They are current wearers of any soft contact lens (i.e. have worn lenses in the last six months).

5. They have refractive ocular astigmatism between 0.00DC and -1.50DC in one or both eyes.

6. They have a spherical component to their ocular refractive error between 0.00 and - 6.00 DS.

7. They could attain at least 0.10 logMAR distance high contrast visual acuity in one eye with the study lenses within the available power range.

8. They can be fitted satisfactorily with both lens types.

9. They own an acceptable pair of spectacles.

10. They agree not to participate in other clinical research for the duration of this study. Exclusion Criteria: -

Subjects will not be eligible to take part in the study if:

1. They have an ocular disorder which would normally contra-indicate contact lens wear.

2. They have a systemic disorder which would normally contra-indicate contact lens wear.

3. They are using any topical medication such as eye drops or ointment.

4. They have had corneal refractive surgery.

5. They have any corneal distortion resulting from previous hard or rigid lens wear or have keratoconus.

6. They are pregnant or breastfeeding.

7. They have any ocular abnormality which would, in the opinion of the investigator, normally contraindicate contact lens wear.

8. They have an amblyopic eye, in which case only dominant eye will be assessed for that subject.

9. They have an infectious disease (e.g. hepatitis), any immunosuppressive disease (e.g. HIV) or diabetes.

10. They have a history of severe allergic reaction or anaphylaxis.

11. They have taken part in any other contact lens clinical trial or research, within two weeks prior to starting this study.

Related Conditions & MeSH terms

• Astigmatism

Intervention

Device:
• Soft Toric Custom Made Contact lens
Subjects will be randomized to wear soft toric custom made lenses for 30 minutes in one eye with other eye patched.
• Soft Spherical Contact Lenses
Subjects will be randomized to wear soft spherical contact lenses for 30 minutes in one eye with other eye patched.
• Spectacle Correction
Subjects will be randomized to wear spectacle Correction for 30 minutes in one eye with other eye patched.

Locations

Country	Name	City	State
United Kingdom	Eurolens Research	Manchester

Sponsors (1)

Lead Sponsor	Collaborator
Coopervision, Inc.

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Visual Acuity	Visual acuity was assessed using logMAR for each intervention.	Baseline with low contrast VA
Primary	Visual Acuity	Visual acuity was assessed using logMAR for each intervention.	After 30 minutes of dispense (Low Contrast VA)
Primary	Visual Acuity	Visual acuity was assessed using logMAR for each intervention.	Baseline with High contrast VA
Primary	Visual Acuity	Visual acuity was assessed using logMAR for each intervention.	After 30 minutes of dispense (High Contrast VA)
Secondary	Slit Lamp Biomicroscopy Findings - Conjunctival Redness	Slit lamp Biomicroscopy findings were assessed on Efron Grading scales scored to the nearest 0.1 on a scale of 0 - 4 (0=normal, 1=trace, 2=mild, 3=moderate, 4=severe).; The assessments done were recorded prior to the first intervention.; Here the time frame used is "Entrance" which refers to the time prior to wear of study lens.	Entrance (Prior to wear of study lens)
Secondary	Slit Lamp Biomicroscopy Findings - Conjunctival Redness	Slit lamp Biomicroscopy findings were assessed on Efron Grading scales scored to the nearest 0.1 on a scale of 0 - 4 (0=normal, 1=trace, 2=mild, 3=moderate, 4=severe).; The assessments were done following the removal of the third intervention. Here the time frame used is "Exit" which refers to those measurements taken post-lens/spectacle wear.	At Exit (After 30 minutes in each of three interventions)
Secondary	Slit Lamp Biomicroscopy Findings - Limbal Redness	Slit lamp Biomicroscopy findings were assessed on Efron Grading scales scored to the nearest 0.1 on a scale of 0 - 4 (0=normal, 1=trace, 2=mild, 3=moderate, 4=severe).; The assessments done were recorded prior to the first intervention. Here the time frame used is "Entrance" which refers to the time prior to wear of study lens.	Entrance (Prior to wear of study lens)
Secondary	Slit Lamp Biomicroscopy Findings - Limbal Redness	Slit lamp Biomicroscopy findings were assessed on Efron Grading scales scored to the nearest 0.1 on a scale of 0 - 4 (0=normal, 1=trace, 2=mild, 3=moderate, 4=severe).; The assessments were done following the removal of the third intervention. Here the time frame used is "Exit" which refers to those measurements taken post-lens/spectacle wear.	At Exit (After 30 minutes in each of three interventions)
Secondary	Slit Lamp Biomicroscopy Findings - Corneal Staining	Slit lamp Biomicroscopy findings were assessed on Efron Grading scales scored to the nearest 0.1 on a scale of 0 - 4 (0=normal, 1=trace, 2=mild, 3=moderate, 4=severe).; The assessments done were recorded prior to the first intervention. Here the time frame used is "Entrance" which refers to the time prior to wear of study lens.	Entrance (Prior to wear of study lens)
Secondary	Slit Lamp Biomicroscopy Findings - Corneal Staining	Slit lamp Biomicroscopy findings were assessed on Efron Grading scales scored to the nearest 0.1 on a scale of 0 - 4 (0=normal, 1=trace, 2=mild, 3=moderate, 4=severe).; The assessments were done following the removal of the third intervention. Here the time frame used is "Exit" which refers to those measurements taken post-lens/spectacle wear.	At Exit (After 30 minutes in each of three interventions)
Secondary	Slit Lamp Biomicroscopy Findings - Conjunctival Staining	Slit lamp Biomicroscopy findings were assessed on Efron Grading scales scored to the nearest 0.1 on a scale of 0 - 4 (0=normal, 1=trace, 2=mild, 3=moderate, 4=severe).; The assessments done were recorded prior to the first intervention.; Here the time frame used is "Entrance" which refers to the time prior to wear of study lens.	Entrance (Prior to wear of study lens)
Secondary	Slit Lamp Biomicroscopy Findings - Conjunctival Staining	Slit lamp Biomicroscopy findings were assessed on Efron Grading scales scored to the nearest 0.1 on a scale of 0 - 4 (0=normal, 1=trace, 2=mild, 3=moderate, 4=severe).; The assessments were done following the removal of the third intervention. Here the time frame used is "Exit" which refers to those measurements taken post-lens/spectacle wear.	At Exit (After 30 minutes in each of three interventions)
Secondary	Slit Lamp Biomicroscopy Findings - Papillary Conjunctivitis	Slit lamp Biomicroscopy findings were assessed on Efron Grading scales scored to the nearest 0.1 on a scale of 0 - 4 (0=normal, 1=trace, 2=mild, 3=moderate, 4=severe).; The assessments done were recorded prior to the first intervention.; Here the time frame used is "Entrance" which refers to the time prior to wear of study lens.	Entrance (Prior to wear of study lens)
Secondary	Slit Lamp Biomicroscopy Findings - Papillary Conjunctivitis	Slit lamp Biomicroscopy findings were assessed on Efron Grading scales scored to the nearest 0.1 on a scale of 0 - 4 (0=normal, 1=trace, 2=mild, 3=moderate, 4=severe).; The assessments were done following the removal of the third intervention.; Here the time frame used is "Exit" which refers to those measurements taken post-lens/spectacle wear.	At Exit (After 30 minutes in each of three interventions)
Secondary	Slit Lamp Biomicroscopy Findings - Corneal Oedema	Slit lamp Biomicroscopy findings were assessed on Efron Grading scales scored to the nearest 0.1 on a scale of 0 - 4 (0=normal, 1=trace, 2=mild, 3=moderate, 4=severe).; The assessments done were recorded prior to the first intervention. Here the time frame used is "Entrance" which refers to the time prior to wear of study lens.	Entrance (Prior to wear of study lens)
Secondary	Slit Lamp Biomicroscopy Findings - Corneal Oedema	Slit lamp Biomicroscopy findings were assessed on Efron Grading scales scored to the nearest 0.1 on a scale of 0 - 4 (0=normal, 1=trace, 2=mild, 3=moderate, 4=severe).; The assessments were done following the removal of the third intervention.; Here the time frame used is "Exit" which refers to those measurements taken post-lens/spectacle wear.	At Exit (After 30 minutes in each of three interventions)